An Observational, Multicenter, Retrospective, International Study To Assess The Safety And Efficacy Of Romiplostim and Eltrombopag During Pregnancy Primary Or Secondary Immune Thrombocytopenia
Latest Information Update: 15 Dec 2019
At a glance
- Drugs Eltrombopag (Primary) ; Romiplostim
- Indications Thrombocytopenia
- Focus Adverse reactions; Therapeutic Use
Most Recent Events
- 15 Dec 2019 New trial record
- 10 Dec 2019 Results (N= 13), preliminary analysis assessing the safety and efficacy of Romiplostim and Eltrombopag during pregnancy treated for primary or secondary immune thrombocytopenia. presented at the 61st Annual Meeting and Exposition of the American Society of Hematology